Rakesh Bam is a highly accomplished Research Scientist with over a decade of experience in molecular biology, specializing in both solid and hematological cancer types. He has received his research training from prestigious institutions such as the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences and the departments of Radiation Oncology and Radiology at Stanford University.
Rakesh Bam has published numerous articles in peer-reviewed journals such as Blood, Clinical Cancer Research, American Journal of Hematology, Blood Cancer Journal (Nature), and Investigative Radiology, covering topics such as tumor-immune microenvironment, targeted drug development, cell biology, and molecular diagnostic imaging for the early detection of cancer. He is skilled in CRISPR, plasmid cloning, flow cytometry, PCR, protein engineering and expression, cell signaling and RNA-Seq analysis, molecular probe and conjugate synthesis, immune profiling, drug screening, and cell sorting.
In addition to laboratory research, Rakesh Bam has mentored undergraduate, graduate/medical students, visiting scholars, and postdoctoral fellows. Furthermore, he has led projects for external industry partners and has presented in international conferences and faculty meetings. His current research focus area is contrast agent synthesis and the development of new drug screening platforms within the evolving field of cancer Theranostics.
Outside of his profession, Rakesh Bam enjoys learning about astrobiology, meditation, writing, traveling, and sports. He has a Bachelor's degree in Biochemistry from Southern Arkansas University and a PhD in Interdisciplinary Biomedical Sciences (Cancer Track) from the University of Arkansas for Medical Sciences. Currently, he works as a Research Scientist at Stanford University.